HEATHROW, FL -- (MARKET WIRE) -- May 21, 2007 -- IDenta Corp. (PINKSHEETS: IDTA) announced today that it has signed a comprehensive co-branding and marketing agreement with Jant Pharmacal Corporation. The agreement comes seven months after IDenta agreed to co-brand its line of drug detection products with Jant’s own Accutest® label. Details of the comprehensive agreement were finalized during the recent U.S. marketing mission when officials from IDenta spent six days in the Los Angeles marketplace including significant time at the Jant Pharmacal Corporation headquarters in Encino, California. www.accutest.net
